Theraclion
France corporation · 1 known investors
Theraclion develops robotic ultrasound-based medical devices for non-invasive treatment of vascular and endocrine conditions, including systems for varicose veins, thyroid nodules, and breast fibroadenomas. The company serves healthcare providers and patients seeking minimally invasive alternatives to surgical interventions.
Founders & leadership
MN
Michel NutaExecutive Officer
BV
Bern Von PolheimDirector
SA
Sarah AnkriExecutive Officer
LL
Laurent LevyDirector
SY
Sylvain YonExecutive Officer
FL
Francois LaCosteDirector
AK
Anja KleberExecutive Officer
JB
Jean-Yves BurelDirector
DC
David CaumartinExecutive Officer
PP
Phillippe PoulettyDirector
VG
Vincent GardesDirector
Investors · 1
Reported raises · per SEC filings
Form D private placements▶$250KraisedJul 2015 · 1 investors · BiotechnologyRule 506(b)
▶$250KraisedJul 2015 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Michel NutaExecutive Officer
- Bern Von PolheimDirector
- Sarah AnkriExecutive Officer
- Laurent LevyDirector
- Sylvain YonExecutive Officer
- Francois LaCosteDirector
- Anja KleberExecutive Officer
- Jean-Yves BurelDirector
- David CaumartinExecutive Officer
- Phillippe PoulettyDirector
- Vincent GardesDirector
- Offering amount
- $250K
- Amount sold
- $250K
- Sales commissions
- $12.5K
- Placement agents
- LifeSci Capital LLC
- First sale
- Jun 2015
- Incorporated
- Corporation, France
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.